Award
Delivery Order #SPE2DR26FKKX1
Delivery Order for KEYTRUDA Medication to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$87,455.90
Ceiling
$87,455.90
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 30, 2026
Identifier
SPE2DR26FKKX1
NAICS
424210
This award is a delivery order contract issued under an existing Indefinite Delivery Vehicle (IDV) agreement to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical and medical supplies. The contract involves the procurement of KEYTRUDA 100 MG/4 ML vials, a critical medication used in cancer treatment. The delivery order supports ongoing public health efforts by ensuring timely access to this essential drug. The scope of work covers the supply and delivery of the specified pharmaceutical product within a short-term period in early 2026. This delivery order is part of a competitive acquisition process under the parent IDV contract, which facilitates sustained pharmaceutical procurement. The contract performance is scheduled to occur over several weeks, contributing to the agency’s mission to maintain reliable medical supply chains.
Description
4571131008!KEYTRUDA 100 MG/4 ML VIAL 4ML